Wu Jamie L Y, Ji Qin, Blackadar Colin, Nguyen Luan N M, Lin Zachary P, Sepahi Zahra, Stordy Benjamin P, Granda Farias Adrian, Sindhwani Shrey, Ngo Wayne, Chan Katherine, Habsid Andrea, Moffat Jason, Chan Warren C W
Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.
Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada.
Nat Nanotechnol. 2025 May;20(5):672-682. doi: 10.1038/s41565-025-01877-5. Epub 2025 Mar 17.
The active transport and retention principle is an alternative mechanism to the enhanced permeability and retention effect for explaining nanoparticle tumour delivery. It postulates that nanoparticles actively transport across tumour endothelial cells instead of passively moving through gaps between these cells. How nanoparticles transport across tumour endothelial cells remains unknown. Here we show that nanoparticles cross tumour endothelial cells predominantly using the non-receptor-based macropinocytosis pathway. We discovered that tumour endothelial cell membrane ruffles capture circulating nanoparticles, internalize them in intracellular vesicles and release them into the tumour interstitium. Tumour endothelial cells have a higher membrane ruffle density than healthy endothelium, which may partially explain the elevated nanoparticle tumour accumulation. Receptor-based endocytosis pathways such as clathrin-mediated endocytosis contribute to nanoparticle transport to a lesser extent. Nanoparticle size determines the degree of contribution for each pathway. Elucidating the nanoparticle transport mechanism is crucial for developing strategies to control nanoparticle tumour delivery.
主动转运与滞留原理是一种用于解释纳米颗粒肿瘤递送的、不同于增强渗透与滞留效应的替代机制。该原理假定纳米颗粒是主动穿过肿瘤内皮细胞,而非通过这些细胞之间的间隙被动移动。纳米颗粒如何穿过肿瘤内皮细胞仍是未知的。在此,我们表明纳米颗粒主要通过基于非受体的巨胞饮作用途径穿过肿瘤内皮细胞。我们发现肿瘤内皮细胞膜褶皱捕获循环中的纳米颗粒,将其内化到细胞内囊泡中,然后释放到肿瘤间质中。肿瘤内皮细胞的膜褶皱密度高于健康内皮细胞,这可能部分解释了纳米颗粒在肿瘤中积累增加的现象。基于受体的内吞作用途径,如网格蛋白介导的内吞作用,对纳米颗粒转运的贡献较小。纳米颗粒的大小决定了每种途径的贡献程度。阐明纳米颗粒转运机制对于制定控制纳米颗粒肿瘤递送的策略至关重要。